STAT1: a modulator of chemotherapy-induced apoptosis - PubMed (original) (raw)
STAT1: a modulator of chemotherapy-induced apoptosis
Michelle Thomas et al. Cancer Res. 2004.
Abstract
The anthracyclines, such as doxorubicin, are widely used in the treatment of breast cancer. Previously, we showed that these drugs could activate the transcription factor, nuclear factor kappaB, in a DNA damage-dependent manner. We now show that these drugs can potentiate the activation of signal transducer and activator of transcription 1 (STAT1) in MDA-MB 435 breast cancer cells treated with IFN-gamma. We observed that key markers of STAT1 activation, including tyrosine 701 and serine 727 phosphorylation, were enhanced in the presence of doxorubicin. This potentiation resulted in enhanced nuclear localization of activated STAT1 and led to an increase in the nuclear binding of activated STAT complexes. The observed potentiation was specific for STAT1 and IFN-gamma, as no effects were observed with either STAT3 or STAT5. Furthermore, the type I IFNs (alpha and beta) had little or no effect. The observed effects on STAT1 phosphorylation have previously been linked with maximal transcriptional activation and apoptosis. Cell viability was assessed by crystal violet staining followed by analysis with CalcuSyn to determine combination index values, a measure of synergy. We confirmed that significant synergy existed between IFN-gamma and doxorubicin (combination index = 0.34) at doses lower than IC(50) values for this drug (0.67 micromol/L). In support of this, we observed that apoptotic cell death was also enhanced by measuring poly(ADP-ribose) polymerase and caspase-3 cleavage. Finally, suppression of STAT1 expression by small-interfering RNA resulted in a loss of synergistic apoptotic cell death compared with cells, where no suppression of STAT1 expression was attained with scrambled small-interfering RNA control. We conclude that doxorubicin potentiates STAT1 activation in response to IFN-gamma, and that this combination results in enhanced apoptosis in breast cancer cells.
Similar articles
- Fas- and interferon gamma-induced apoptosis in Chang conjunctival cells: further investigations.
De Saint Jean M, Debbasch C, Rahmani M, Brignole F, Feldmann G, Warnet JM, Baudouin C. De Saint Jean M, et al. Invest Ophthalmol Vis Sci. 2000 Aug;41(9):2531-43. Invest Ophthalmol Vis Sci. 2000. PMID: 10937564 - IFN-gamma/JAK/STAT pathway-induced inhibition of DR4 and DR5 expression on endothelial cells is cancelled by cycloheximide-sensitive mechanism: novel finding of cycloheximide-regulating death receptor expression.
Tanaka F, Kawakami A, Tamai M, Nakamura H, Iwanaga N, Izumi Y, Arima K, Aratake K, Huang M, Kamachi M, Ida H, Origuchi T, Eguchi K. Tanaka F, et al. Int J Mol Med. 2005 May;15(5):833-9. Int J Mol Med. 2005. PMID: 15806306 - Stat1-mediated cytoplasmic attenuation in osteoimmunology.
Takayanagi H, Kim S, Koga T, Taniguchi T. Takayanagi H, et al. J Cell Biochem. 2005 Feb 1;94(2):232-40. doi: 10.1002/jcb.20316. J Cell Biochem. 2005. PMID: 15546140 Review. - STAT-1: a novel regulator of apoptosis.
Stephanou A, Latchman DS. Stephanou A, et al. Int J Exp Pathol. 2003 Dec;84(6):239-44. doi: 10.1111/j.0959-9673.2003.00363.x. Int J Exp Pathol. 2003. PMID: 14748743 Free PMC article. Review.
Cited by
- Targeting IFN/STAT1 Pathway as a Promising Strategy to Overcome Radioresistance.
Liu S, Imani S, Deng Y, Pathak JL, Wen Q, Chen Y, Wu J. Liu S, et al. Onco Targets Ther. 2020 Jun 24;13:6037-6050. doi: 10.2147/OTT.S256708. eCollection 2020. Onco Targets Ther. 2020. PMID: 32606809 Free PMC article. Review. - HDAC4-regulated STAT1 activation mediates platinum resistance in ovarian cancer.
Stronach EA, Alfraidi A, Rama N, Datler C, Studd JB, Agarwal R, Guney TG, Gourley C, Hennessy BT, Mills GB, Mai A, Brown R, Dina R, Gabra H. Stronach EA, et al. Cancer Res. 2011 Jul 1;71(13):4412-22. doi: 10.1158/0008-5472.CAN-10-4111. Epub 2011 May 13. Cancer Res. 2011. PMID: 21571862 Free PMC article. - Direct and indirect effects of IFN-α2b in malignancy treatment: not only an archer but also an arrow.
Xiong F, Wang Q, Wu GH, Liu WZ, Wang B, Chen YJ. Xiong F, et al. Biomark Res. 2022 Sep 14;10(1):69. doi: 10.1186/s40364-022-00415-y. Biomark Res. 2022. PMID: 36104718 Free PMC article. Review. - Unphosphorylated STAT1 promotes sarcoma development through repressing expression of Fas and bad and conferring apoptotic resistance.
Zimmerman MA, Rahman NT, Yang D, Lahat G, Lazar AJ, Pollock RE, Lev D, Liu K. Zimmerman MA, et al. Cancer Res. 2012 Sep 15;72(18):4724-32. doi: 10.1158/0008-5472.CAN-12-1347. Epub 2012 Jul 17. Cancer Res. 2012. PMID: 22805310 Free PMC article. - A STAT3-decoy oligonucleotide induces cell death in a human colorectal carcinoma cell line by blocking nuclear transfer of STAT3 and STAT3-bound NF-κB.
Souissi I, Najjar I, Ah-Koon L, Schischmanoff PO, Lesage D, Le Coquil S, Roger C, Dusanter-Fourt I, Varin-Blank N, Cao A, Metelev V, Baran-Marszak F, Fagard R. Souissi I, et al. BMC Cell Biol. 2011 Apr 12;12:14. doi: 10.1186/1471-2121-12-14. BMC Cell Biol. 2011. PMID: 21486470 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous